Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.
Press releases published on August 27, 2025

NVIDIA Announces Financial Results for Second Quarter Fiscal 2026
Revenue of $46.7 billion, up 6% from Q1 and up 56% from a year ago Data Center revenue of $41.1 billion, up 5% from Q1 and up 56% from a year ago Blackwell Data Center revenue grew 17% sequentially SANTA CLARA, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- …

Kirby McInerney LLP Reminds Replimune Group, Inc. Investors of Class Action Filing and Encourages Investors to Contact the Firm
NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@ …

Calian Reaffirms Strategic Direction and Commitment to Long-Term Shareholder Value
OTTAWA, Ontario, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Calian® Group Ltd. (“Calian” or the “Company”) (TSX:CGY) (TSX:CGY), a mission-critical solutions company focused on defence, space, healthcare and other strategic critical infrastructure sectors, …

Supernus Pharmaceuticals to Participate in September Investor Conferences
ROCKVILLE, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today …

Invitation to Martin Marietta’s Capital Markets Day on September 3, 2025
RALEIGH, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Martin Marietta Materials, Inc. (NYSE: MLM) (Martin Marietta or the Company), a leading national supplier of aggregates and heavy building materials, invites investors and analysts to the live broadcast of …

Anaptys Announces Participation in September Investor Conferences
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of …

Synergy CHC Corp. Announces the Closing of its $4.375 Million Public Offering
WESTBROOK, Maine, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (Nasdaq: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced the closing of an underwritten public offering of 1,750,000 shares of common …

Bespoke Extracts, Inc. Announces Financial Results for the Second Quarter ended June 30, 2025
AURORA, Colo., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (“Bespoke” or the “Company”) (OTCQB: BSPK), today reported its financial results for the quarter ended June 30, 2025. Financial results are reported in accordance with U.S. generally …

Aardvark Therapeutics to Present at Upcoming Investor Conferences in September
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the …

Acarpia Farmaceutici and EarlyHealth Group Expand Their Partnership to Improve Access in CARICOM and Mexico
MILAN, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Acarpia Farmaceutici S.r.l., an Italian pharmaceutical manufacturer, and EarlyHealth Group, a global pharmaceutical service provider, have announced the expansion of their strategic partnership to improve access to …

Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, …

MannKind to Present at Upcoming Investor Conferences
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with …

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …

Andrew Ross Joins Symbotic’s Board of Directors
WILMINGTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, today announced the election of Andrew (“Andy”) Ross to its Board of Directors, effective August 26, 2025. …

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
SALT LAKE CITY, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences. The Wells …

Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025
FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical …

HP Inc. Reports Fiscal 2025 Third Quarter Results
PALO ALTO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- HP (NYSE: HPQ) Third quarter GAAP diluted net earnings per share ("EPS") of $0.80, up 23.1% from the prior year period Third quarter non-GAAP diluted net EPS of $0.75, down 10.7% from the prior year …

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
CANTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program
MINNEAPOLIS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the U.S. Food and Drug Administration (“FDA”) agreed to accept its …

MDB Capital Holdings Provides Second Quarter 2025 Update
Addison, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading “Big Idea” companies, today provides an operational update for the quarter ended June 30, 2025 …